About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
R
Experts Discuss the Use of Bispecific Antibodies in NHL
By
MyCancerHaven
FEATURING
Ravi Vij
,
Brad Kahl
By
MyCancerHaven
FEATURING
Ravi Vij
,
Brad Kahl
79 views
January 24, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Related Content
AUTOPLAY
ON
13:07
Moffitt Cancer Center
R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?
Feat.
J. Chavez
09:18
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Random…
Feat.
J. Westin
06:33
Christopher Flowers
FDA Approval of Zanubrutinib in R/R FL: What You Need to Know
10:04
Tara Graff
How to Incorporate Bispecific Antibodies Into Your NHL Practice: A P…
08:23
Total Health
R/R DLBCL Case Discussion: 81 y/o Male Needing 3rd Line Treatment
Feat.
J. Chandler,
B. Randolph,
M. Onciu
13:56
SOHO 2023 Eleventh Annual Meeting
Follicular Lymphoma Management: What Is the New Order?
Feat.
B. Kahl
62:02
UChicago Medicine
New Treatment Strategies in DLBCL
Feat.
L. Sehn
09:45
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Therapeutic Options for Pts With Primary …
Feat.
M. Kamdar
16:03
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: The New Algorithm for 2L LBCL
Feat.
J. Westin
15:26
Moffitt Cancer Center
R/R DLBCL: Are CAR-Ts Superior to Bispecific Antibodies?
Feat.
A. Lazaryan
27:51
Louisville Hematology Highlights
Summary of Recent Advances in Follicular Lymphoma
Feat.
S. Gaballa
19:46
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024
Management of Indolent NHL
Feat.
E. Brem
17:21
Daniel Addison
Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…
10:27
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Rates of CRS and ICANS From CIBMTR Data o…
Feat.
J. DiPersio
25:44
Tara Graff
DLBCL Updates From iCML 2023
06:09
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Outcomes of Pts With Richter's Transfo…
Feat.
A. Kittai
07:06
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Putting the CAR-T Before the Horse - Impr…
Feat.
L. Shune
08:58
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Zanubrutinib + Obinutuzumab vs. Obinutuzu…
Feat.
C. Flowers
05:38
GRACE
Epcoritamab in NHL - Incidence and Management of CRS
Feat.
T. Phillips
35:28
UNC Lineberger Comprehensive Cancer Center
DLBCL Management: Updates for 2023
Feat.
N. Grover
